ITALIAN DRUG DISCOVERY SUMMIT 2014 Second Edition June 18th (2 PM opening) - 19th, 2014 (3 PM closing) Openzone Via Meucci 3 - 20091 Bresso - Milan DESCRIPTION Nowadays the scientific and organizational landscape of the drug discovery process is in a state of rapid evolution. Cost driven externalization of research activities has demonstrated poor returns in terms of quality and productivity. New open models of precompetitive collaboration, creation of networks of competences, knowledge driven drug discovery programs’ are today the most promising strategies to address the increasing need of innovation. Moreover new players are entering in the Drug Discovery field such as charities and patient association that are expected to provide an increasing role in the process, changing the focus from basic research to late stage develop of new drugs. In the current scenario innovation for new drugs requires new ideas to translate basic research, into new medicines, approaches. This meeting will focus on addressing today’s challenges in Italian drug discovery with an emphasis on novel business models and emerging organizational approaches to more effective translation. Aim of the meeting is to promote the implementation of novel organizational model for drug discovery with an emphasis on public/private enabling networks. The meeting will bring together different Italian drug discovery oriented organizations, along with testimonials of the most successful implementations of novel paradigms of Drug Discovery and Development, with specific focus on rare diseases and orphan drugs. ORGANIZERS Andrea R. Beccari - Dompé Angelo Reggiani - IIT-D3 PATRONAGE SPONSOR CMYK BICROMIA ITALIAN DRUG DISCOVERY SUMMIT 2014 Second Edition June 18th (2 PM opening) - 19th, 2014 (3 PM closing) Openzone Via Meucci 3 - 20091 Bresso - Milan Agenda – DAY ONE – June 18th, 2014 Agenda – DAY TWO – June 19th, 2014 14:00 - Registration 9:00 - Italian Drug Discovery initiative 14:30 - Welcome Elena Zambon, President of Zambon S.p.A. Alessandro Sidoli, President of Assobiotec Chairman: Angelo Reggiani (IIT-D3) Andrea R. Beccari (Dompé) Lucio Da Ros (Aptuit) Vincenzo Summa (IRBM) 15:00 - 20:00 Drug Discovery in the next 5 years: the different perspectives 9:30 - Round Table: Age of (R)evolution or Extinction? 15:00 - The perspective from the pharmaceutical industry Marcello Allegretti (Dompé) Luca Benatti (Erydel) Simone Braggio (Aptuit) Francesco Di Marco (Amgen) Giuseppe Martini (Cluster ALISEI) Francesca Pasinelli (Telethon) Diego Provvedini (Recordati) Graziano Seghezzi (Sofinnova) Chairman: Alessandro Sidoli (Assobiotec) Andrea Chiesi (Chiesi) Francesco Di Marco (Amgen) Daniele Alberti (Novartis) Maurizio Castorina (Zambon) 16:30 - Coffee Break 17:00 - The other actors in the pipeline Chairman: Luca Benatti (Assobiotec) Biotech: Stefan Lohmer (Axxam) CRO: Simone Braggio (Aptuit) Charity: Lucia Faccio (Telethon) Venture Capital: Graziano Seghezzi (Sofinnova) Patient Advocacy Foundations: Gianni Mastella (Cystic Fibrosis Foundation) Academy: Gabriele Costantino (UniPr DCF-SCI) 19:00 - Discussion and concluding remarks Chairman: Alessandro Sidoli (Assobiotec) 12:30 - Recapitulation Andrea R. Beccari (Dompé) Angelo Reggiani (IIT-D3) 12:45 - Closing Alessandro Sidoli, President of Assobiotec 13:00 - Lunch 14:00 - Meet Italian Drug Discovery Group 15:00 - End Andrea R. Beccari (Dompé) Angelo Reggiani (IIT-D3) 20.00 - Dinner ORGANIZATION AND PRESS OFFICE For further details and free registration: Baboon Comunicazione, Via Palermo 8, 20121 Milan Tel: +39 02 89093874 - baboon.it - email@example.com We would like to encourage you to register for this important event no later than June 9th as participation to conference is subject to seats available.